Browse > Article
http://dx.doi.org/10.5012/jkcs.2007.51.6.536

Molecular Genetic Analysis of Behcet's Disease in Korean  

Park, Sang-Bum (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Nam, Youn-Hyoung (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Park, Su-Min (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Lee, Sang-Hyun (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Ahn, Young-Chang (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Cho, Min-Ho (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Kim, Jong-Gyu (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Choi, Jae-Gu (Department of Environmental Science, Dongnam Health College)
Kim, Seong-Kyu (Department of Internal Medicine, Catholic University of Daegu, School of Medicine)
Jang, Won-Cheoul (Department of Chemistry, School of Advanced Science and Basic Science Research Institute, Dankook University)
Publication Information
Journal of the Korean Chemical Society / v.51, no.6, 2007 , pp. 536-542 More about this Journal
Abstract
Behcet's disease (BD) is a chronic inflammatory disorder, involving several organs. Inflammation in the disease is thought to be mediated by cytokines derived from T-helper type 1 (Th1) lymphocytes. Although the exact pathogenesis for BD is not completely understood, it has been suggested that the disease is triggered in genetically susceptible individuals by environmental factors, such as microbial agents. It is noted that multiple genes, including MHC (major histocompatibility complex) and non-MHC genes, are implicated in the pathogenesis of BD. This study tries to determine whether HLA-B51, IL-18, SLC11A1 and TNF-α polymorphisms are associated with susceptibility to Behcet's disease in Koreans. As a results, HLA-B51 was a genetic factor with the strongest association with BD. But it is still uncertain whether this HLA molecule is directly involved in the pathogenesis of BD. Although the IL-18 gene polymorphisms were not associated with a susceptibility to BD in the Korean population, the patients carrying the GG genotype at position 137 had a higher risk of developing the ocular lesions. This study suggests that the allele 3 and the genotype allele 3 / allele 3 of 5'-promoter (GT)n polymorphism in the SLC11A1 gene may have a protective effect for the development of BD in the Korean population. There were no evidences for genetic association conferred by the TNF-α gene with respect to susceptibility to BD.
Keywords
BD (behcet's disease); HLA-B51; IL-18; SLC11A1; TNF-${\alpha}$;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Lee, E. B.; Kim, J. Y.; Lee, Y. J.; Park, M. H.; Song, Y. W. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol 2003, 64,614-20   DOI   ScienceOn
2 Kaklamani, V. G.; Vaiopoulos, G.; Kaklamanis, P. G. Behcet's Disease. Semin Arthritis Rheum 1998, 27, 197-217   DOI   ScienceOn
3 Chang, H. K.; Kim, J. U.; Lee, S. S.; Yoo, D. H. Lack of association between angiotensin converting enzyme gene polymorphism and Korean Behcet's disease. Ann Rheum Dis 2004, 63, 106-7   DOI   ScienceOn
4 Chang, H. K.; Cheon, K. S. The clinical significance of a pathergy reaction in patients with Behcet's disease. J Korean Med Sci 2002, 17, 371-4   DOI   ScienceOn
5 Arayssi, T.; Hamdan, A. New insights into the pathogenesis and therapy of Behcet's disease. Curr Opin Pharmacol 2004, 4, 183-8   DOI   ScienceOn
6 Fresko, I., Soy, M., Hamuryudan, V., Yurdakul, S., Yavuz, S., Tumer, Z. et al. Genetic anticipation in Behcet's syndrome. Ann Rheum Dis 1998, 57, 45-8   DOI   ScienceOn
7 Inaba, G. Clinical features of neuro-Behcet's syndrome. In: Lehner T, Barnes CG, eds. Recent advances in Behcet's disease. London, Royal Society of Medicine Services 1986, 235-46
8 Eksioglu-Demiralp, E.; Direskeneli, H.; Kibaroglu, A.; Yavuz, S.; Ergun, T.; Akoglu, T. Neutrophil activation in Behcet's disease. Clin Exp Rheumatol 2001, 19(Suppl 24), S19-24
9 Wallace, G. R.; Verity, D. H.; Delamaine, L. J.; Ohno, S.; Inoko, H.; Ota, M. et al: MIC-A allele profiles and HLA class I associations in Behcet's disease. Immunogenetics 1999, 49, 613-7   DOI
10 Turan, B.; Gallati, H.; Erdi, H.; Gurler, A.; Michel, B. A.; Villiger, P. M. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechcet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997, 24, 128-32   DOI
11 Yazici, H. The place of Behcet's syndrome among the autoimmune diseases. Int Rev Immunol 1997, 14, 1-10   DOI   ScienceOn
12 Frassanito, M. A.; Dammacco, R.; Cafforio, P.; Dammacco, F. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin- 12. Arthritis Rheum 1999, 42, 1967-74   DOI   ScienceOn